{"reformulated1": "How does the rapid growth rate and high cell density cultivation of Escherichia coli benefit large-scale recombinant protein production compared to yeast and mammalian systems?", "reformulated2": "What genetic tools and engineered Escherichia coli strains are most effective for optimizing recombinant protein yield and solubility in laboratory and industrial settings?", "reformulated3": "Which technical advantages of Escherichia coli make it particularly suitable for producing non-glycosylated therapeutic proteins at the industrial scale?"}
